High-resolution fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of a pituitary microtumor in a dog

A 16-year-old, castrated, male English cocker spaniel dog was presented due to generalized alopecia. Routine clinical pathology, endocrine and abdominal ultrasonography results were consistent with a diagnosis of pituitary-dependent hyperadrenocorticism. The adenohypophyseal lesion was clearly visualized on both 3 T and 7 T magnetic resonance imaging (MRI) of the pituitary gland. Although biochemical and MRI findings were consistent with a functional pituitary microtumor, a pituitary lesion was not detected using ¹⁸F-fluorodeoxyglucose positron emission tomography (FDG-PET). This report firstly describes the application of high-resolution FDG-PET to a spontaneous pituitary microtumor in a dog.     

Serum adipokine concentrations in dogs with diabetes mellitus: a pilot study

This study was conducted to determine whether serum adipokine concentrations differed between healthy dogs and dogs with diabetes mellitus (DM). To accomplish this, 19 dogs with newly diagnosed DM were compared to 20 otherwise healthy dogs. The serum concentrations of visfatin, leptin, IL-1β, IL-6, IL-18, and TNF-α were significantly higher in diabetic dogs than in healthy dogs, whereas the serum adiponectin concentrations were lower in diabetic dogs. However, there were no significant differences in the IL-10 and resistin levels between groups. The serum leptin concentrations in diabetic dogs with and without concurrent disorders differed significantly. Treatment with insulin induced a significant decrease in IL-6 in diabetic dogs without concurrent disorders. These results show that the clinical diabetic state of dogs could modulate the circulating visfatin and adiponectin concentrations directly, while upregulation of leptin was probably a result of concurrent disorders rather than an effect of persistent hyperglycemia as a result of DM.     

Pharmacokinetics of sanguinarine,chelerythrine, and their metabolites in broiler chickens following oral and intravenous administration

Sanguinarine (SA) and chelerythrine (CHE) are the main active components of the phytogenic livestock feed additive, Sangrovit®. However, little information is available on the pharmacokinetics of Sangrovit® in poultry. The goal of this work was to study the pharmacokinetics of SA, CHE, and their metabolites, dihydrosanguinarine (DHSA) and dihydrochelerythrine (DHCHE), in 10 healthy female broiler chickens following oral (p.o.) administration of Sangrovit® and intravenous (i.v.) administration of a mixture of SA and CHE. The plasma samples were processed using two different simple protein precipitation methods because the parent drugs and metabolites are stable under different pH conditions. The absorption and metabolism of SA following p.o. administration were fast, with half‐life (t_1/2) values of 1.05 ± 0.18 hr and 0.83 ± 0.10 hr for SA and DHSA, respectively. The maximum concentration (C_max) of DHSA (2.49 ± 1.4 μg/L) was higher that of SA (1.89 ± 0.8 μg/L). The area under the concentration vs. time curve (AUC) values for SA and DHSA were 9.92 ± 5.4 and 6.08 ± 3.49 ng/ml hr, respectively. Following i.v. administration, the clearance (CL) of SA was 6.79 ± 0.63 (L·h^?1·kg^?1) with a t_1/2 of 0.34 ± 0.13 hr. The AUC values for DHSA and DHCHE were 7.48 ± 1.05 and 0.52 ± 0.09 (ng/ml hr), respectively. These data suggested that Sangrovit® had low absorption and bioavailability in broiler chickens. The work reported here provides useful information on the pharmacokinetic behavior of Sangrovit® after p.o. and i.v. administration in broiler chickens, which is important for the evaluation of its use in poultry.     

利用限性品种淘汰部分雄蚕进行蚕种生产的探讨

家蚕雄蛾可重复进行数次交配,仍然受精良好,而斑纹限性蚕品种可在幼虫阶段提早进行雌雄鉴别.利用限性品种进行在5龄期前淘汰部分雄蚕,由于减少5龄用桑量,可以达到减少投入提高制种效益的目的.试验用洞庭、碧波为材料,取得了理想的制种效果.     

不同遮荫强度对草地早熟禾草坪质量的影响

为研究不同遮荫强度对新建草地早熟禾(Poa pratensis)草坪生长状况的影响,于2009年5月1日-11月6日进行试验,共设计自然光照、轻度遮荫、中度遮荫和重度遮荫4种不同遮荫强度,对干旱胁迫下草地早熟禾的生长速率、草坪质量、草屑重量、叶色值、电导率和地下生物量等形态指标和生理指标进行观察测定。结果表明,在少雨时节中度遮荫的草坪质量较高,多雨时节则轻度遮荫的草坪质量较好;适度遮荫下草坪草的生长正常,叶色较好,电导率较小,草坪质量较高。因此,可以利用适度遮荫,减少夏季高温与干旱对草地早熟禾草坪的伤害,改善草坪质量。     

中国10个地方鸡种卵壳超微结构研究及聚类分析

对中国 10个地方鸡种卵壳外表面、内表面、横断面和壳膜外表面、内表面的超微结构在扫描电子显微镜下进行了比较研究 ,从而看出鸡种间卵壳结构具有明显差异 ,中国地方鸡种具有遗传多样性。根据遗传距离较近的品种间卵壳的超微结构相似的理论 ,对 10个鸡种的形态结构进行了赋值 ,通过数值分类法进行了遗传相似度的计算和聚类分析 ,从而得出遗传距离最近的是白耳鸡和狼山鸡。     

浅论饲料企业质量管理体系长效机制的构筑

1饲料企业构筑质量管理体系长效机制的必要性1.1进一步全面宣贯ISO9000族标准的需要ISO9000族标准是系列标准,其结构互为补充。企业通过了质量管理体系的认证,仅仅证实企业具有提供"满足顾客要求"和"适用法律法规要求"产品的基本能力。从管理角度来看,这种质量管理体系尚不够完整,从提升企业总体业绩与     

锌源对凡纳滨对虾生长免疫的影响

凡纳滨对虾配合饲料中添加20、40、60、80和100mg/kg硫酸锌和蛋氨酸锌。饲养4和10周称质量,并采集对虾血清、肝胰脏和肌肉,测定血清中酚氧化酶(PO)和碱性磷酸酶(AKP)活性及肝胰脏和肌肉中的锌含量。试验结果表明,锌源和锌水平影响对虾4周末体质量,但对10周末的体质量无影响。锌源和锌水平不影响血清中的PO,但硫酸锌组AKP表现出随添加量的升高而显著提高,蛋氨酸锌组AKP差异不显著。2种锌源的添加水平对肌肉中的锌含量无影响,但对肝胰脏中锌含量影响显著。生长、酶活和组织锌含量的统计结果表明,锌源之间存在显著差异,蛋氨酸锌的营养效果好于硫酸锌。饲料中蛋氨酸锌的添加量为40~60mg/kg时,凡纳滨对虾的生长和免疫效果最好。     

Molecular taxonomic relationships of Psoroptes and Chorioptes mites from China based on COI and 18S rDNA gene sequences

In this present study, the mitochondrial DNA gene cytochrome coxidase subunit I (COI) and the small subunit ribosomal RNA (18S rDNA) gene were used to determine the taxonomic relationships of Psoroptes and Chorioptes mites from China. The neighbor-joining and maximum-parasimony approach were used to evaluate the evolutionary relatedness among different hosts in the genera Psoroptes and Chorioptes. Phylogenetic analysis showed that Psoroptes cuniculi and Psoroptes natalensis may be two different species within the genus Psoroptes, and Chorioptes texanus and Chorioptes panda are different species within the genus Chorioptes.     

Economic evaluation of the surveillance and intervention programme for bluetongue virus serotype 8 in Switzerland

Empirical analyses founded on sound economic principles are essential in advising policy makers on the efficiency of resource use for disease mitigation. Surveillance and intervention are resource-using activities directed at mitigation. Surveillance helps to offset negative disease effects by promoting successful intervention. Intervention is the process of implementing measures (e.g. vaccination or medication) to reduce or remove a hazard in a population. The scale and ratios in which the two are combined affect the efficiency of mitigation, its costs, benefits, and thus net effect on society's well-being. The Swiss national mitigation programme for bluetongue virus serotype 8 was used as case study to investigate the economic efficiency of mitigation. In 2008, Switzerland implemented a vaccination programme to avoid and reduce disease and infection in its ruminant population. To monitor the vaccination programme and the vector dynamics, a surveillance system consisting of serological and entomological surveillance was established. Retrospective analyses for the years 2008-2009 and prospective analyses for the years 2010-2012 were conducted to investigate if the mitigation programme was economically beneficial. In the retrospective analysis, the implemented programme (=comparative scenario) was compared to a hypothesised baseline scenario of voluntary vaccination and surveillance. In the prospective analysis, the comparative scenario assumed to continue was compared to two baseline scenarios: one of voluntary vaccination combined with surveillance and one of no vaccination combined with surveillance. For each scenario, monetary surveillance, intervention and disease costs were calculated. The comparison of baseline and comparative scenarios yielded estimates for the total benefit (=disease costs avoided), margin over intervention cost and the net value of the programme. For 2008-2009, in aggregate, the mean biannual total benefit was 17.46 m Swiss francs (CHF) (1CHF=0.66€ at the time of analysis) and the mean net benefit after subtraction of the intervention and surveillance cost was 3.95 m CHF. For the three years 2010-2012, overall net costs were estimated at 12.93 m and 8.11 m CHF, respectively, for comparison of the implemented mitigation programme with the two baseline scenarios. It was concluded that the surveillance and intervention programme implemented in 2008-2009 was economically beneficial, while its continuation in the same form in 2010-2012 would produce net costs. These costs were due to the mean intervention cost remaining constant at a level of approximately 11 m CHF per year while the mean total benefit would be gradually reduced in 2010-2012 due to the reduced occurrence of disease in a fully vaccinated population.